The Legal Examiner Affiliate Network The Legal Examiner The Legal Examiner The Legal Examiner search instagram avvo phone envelope checkmark mail-reply spinner error close The Legal Examiner The Legal Examiner The Legal Examiner
Skip to main content

Two studies linking the Parkinson’s drug Permax with heart valve damage have resulted in Valeant Pharmaceuticals International pulling the once popular drug from the market. The FDA had asked the drug manufacturer to discontinue marketing the product after the heart valve injury studies. If you are taking or have taken Permax for Parkinson’s disease, you should consult your physician for alternative treatments.

Comments for this article are closed.